Skip to Content
Merck
  • The cholinomimetic agent bethanechol activates IK(ACh) in feline atrial myocytes.

The cholinomimetic agent bethanechol activates IK(ACh) in feline atrial myocytes.

Naunyn-Schmiedeberg's archives of pharmacology (2003-09-10)
Dora E Benavides-Haro, Ricardo A Navarro-Polanco, José A Sánchez-Chapula
ABSTRACT

The effect of the cholinomimetic agent, bethanechol on macroscopic membrane currents was studied in dispersed cat atrial myocytes, using the whole-cell patch-clamp technique. Bethanechol activated an inward rectifying potassium current similar to I(K(ACh)), and a delayed rectifying-like outward current, similar to I(KM3) activated by pilocarpine, choline, and tetramethylammonium, and I(KM4) activated by 4-aminopyridine. The relatively specific muscarinic receptors subtype antagonists methoctramine (M(2)), and tropicamide (M(4)) inhibited both current components induced by bethanechol, suggesting a lack of specificity of these antagonists on cat atrial myocytes. The specific antagonist of M(3) receptors, para-fluoro-hexahydro-siladifenidol did not significantly inhibit the bethanechol-induced currents. In addition, pretreatment with PTX prevented activation of the bethanechol-induced inward and outward currents, suggesting that M(3) receptors are probably not involved in the bethanechol action. The I(K(ACh)) specific blocker tertiapin inhibited both inward rectifying- and delayed rectifying-like currents. These results suggest that both current components result from activation of a single channel type, likely I(K(ACh)).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
p-Fluorohexahydro-sila-difenidol hydrochloride, powder, ≥98% (HPLC)
Pricing and availability is not currently available.